The basics of bladder cancer
Did you know that bladder cancer is the fifth most common cancer in the United States? In fact, the American Cancer Society estimates there will be nearly 75,000 new cases of bladder cancer diagnosed this year. In this article, we’re going to discuss the risk factors, symptoms, early detection and treatment of bladder cancer.
Device found to reduce chemotherapy-induced pain
An estimated 30 to 40 percent of cancer patients treated with chemotherapy experience pain, according to the National Cancer Institute. Known as chemotherapy-induced peripheral neuropathy (CIPN), CIPN can produce sharp pains, numbness, tingling and or burning sensations in the hands and feet of cancer patients because of nerve damage caused by chemotherapy. However, a recent clinical trial utilizing a device first tested at VCU Massey Cancer Center provides further evidence that it can significantly reduce CIPN symptoms without the use of drugs or invasive treatments.
Massey breast cancer expert named among ‘Influential Women of Virginia’
VCU Massey Cancer Center physician and researcher Mary Helen Hackney, M.D., has been named one of the “Influential Women of Virginia” for 2014 by Virginia Lawyers Media.
Few women at high risk for hereditary breast and ovarian cancer are receiving recommended genetic counseling
A new study by VCU Massey Cancer Center researchers finds a critical gap between women eligible for genetic counseling services due to a high familial risk of developing breast and ovarian cancer and those who actually receive it.
Doctoral student crosses disciplines to develop a new therapy for pancreatic cancer
David Durrant is a doctoral candidate in the Department of Biochemistry and Molecular Biology at the VCU School of Medicine. With guidance from Rakesh Kukreja, M.S., Ph.D., he is making significant progress testing a new combination therapy for pancreatic cancer, and many in the field of pharmacology are taking notice.